Australian Gonococcal Surveillance Programme, 1 October to 31 December 2022

Authors

  • Monica M Lahra World Health Organization Collaborating Centre for STI and AMR, Sydney and Neisseria Reference Laboratory, NSW Health Pathology, Microbiology, Prince of Wales Hospital, Randwick, NSW, 2031, Australia; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Kensington, NSW 2052, Australia
  • Siobhan M Hurley NSW Health Pathology, Microbiology, Prince of Wales Hospital, Randwick, NSW, 2031, Australia
  • Sebastiaan Van Hal Molecular Microbiology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia
  • Tiffany R Hogan World Health Organization Collaborating Centre for STI and AMR, Sydney and Neisseria Reference Laboratory, NSW Health Pathology, Microbiology, Prince of Wales Hospital, Randwick, NSW, 2031, Australia

DOI:

https://doi.org/10.33321/cdi.2023.47.30

Keywords:

antimicrobial resistance, disease surveillance, gonococcal infection, Neisseria gonorrhoeae

Abstract

The Australian National Neisseria Network (NNN) comprises reference laboratories in each state and territory that report data on antimicrobial susceptibility testing to an agreed group of antimicrobial agents for the Australian Gonococcal Surveillance Programme (AGSP). This report presents national gonococcal antimicrobial resistance surveillance data for the indicated quarter.

Downloads

Download data is not yet available.

References

World Health Organization (WHO). Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Geneva: WHO; 2012. Available from: https://apps.who.int/iris/handle/10665/44863.

Lahra MM, Hurley SM, Hogan TR. Australian Gonococcal Surveillance Programme, 1 July to 30 September 2022. Commun Dis Intell (2018). 2023;47. doi: https://doi.org/10.33321/cdi.2023.47.29.

Day M, Pitt R, Mody N, Saunders J, Rai R, Nori A et al. Detection of 10 cases of ceftriaxone-resistant Neisseria gonorrhoeae in the United Kingdom, December 2021 to June 2022. Euro Surveill. 2022;27(46):2200803. https://doi.org/10.2807%2F1560-7917.ES.2022.27.46.2200803

Lahra MM, Armstrong BH, Hogan TR. Australian Gonococcal Surveillance Programme Annual Report 2021. Commun Dis Intell (2018). 2022;46. https://doi.org/10.33321/cdi.2022.46.52.

Unemo M. Current and future antimicrobial treatment of gonorrhoea – the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis. 2015;15:364. doi: https://doi.org/10.1186/s12879-015-1029-2.

Downloads

Published

25/05/23

How to Cite

Lahra, Monica M, Siobhan M Hurley, Sebastiaan Van Hal, and Tiffany R Hogan. 2023. “Australian Gonococcal Surveillance Programme, 1 October to 31 December 2022 ”. Communicable Diseases Intelligence 47 (May). https://doi.org/10.33321/cdi.2023.47.30.

Issue

Vol. 47 (2023)

Section

Quarterly report

Categories

License

Copyright (c) 2023 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>